Medical Devices & Pharma Articles
Blackstoneās Head of Life Sciences, Dr Nicholas Galakatos, says Pfizerās GLP-1 drug berobenatide has the potential to be a āfirst-in-classā treatment
This week's top stories include Pfizer's appointment of Cecile Guegan as CFO, Regeneron's strong Q3 performance and Cancer Research UK's media partnership
Siemens Healthineers CEO Bernd Montag says Siemens will remain part of "our heritage" but is ready to write the "next chapters of our journey"
AbbVieās more than Ā£120m (US$161m) investment will harness Oxfordās āleading life sciences ecosystem,ā says Global Head of Discovery Research Jon Sedgwick
CEO Albert Bourla describes Pfizerās Q3 2026 results as demonstrating āstrong momentumā, as the firm also appointed Cecile Guegan as permanent CFO
CEO Leonard Schleifer describes Q3 2026 as an āoutstanding quarterā for Regeneron, as Dupixent, EYLEA HD and Libtayo each achieved record net sales
GSKās Hesham Abdullah says novel cancer treatments and drug development advances are ācreating opportunities that simply weren't possible a decade agoā
This week's top stories include Stryker's CEO change, Viatris' pain management deal, J&J's Q3 earnings and Flo and Google's femtech partnership